期刊文献+

九节龙皂苷Ⅰ对口腔黏液表皮样癌Mc3细胞的增殖抑制作用 被引量:3

Inhibition of the proliferation of human mucoepidermoid carcinoma Mc3 cells by ardipusilloside Ⅰ
下载PDF
导出
摘要 目的:研究九节龙皂苷Ⅰ(ardipusilloside Ⅰ)对口腔黏液表皮样癌Mc3细胞的增殖抑制与促细胞凋亡作用,以探讨九节龙皂苷Ⅰ的抗肿瘤作用机制。方法:利用MTT法检测九节龙皂苷Ⅰ对Mc3细胞生长抑制率的影响;采用FCM观察细胞周期并检测细胞凋亡率。结果:九节龙皂苷Ⅰ作用于Mc3细胞,在小剂量情况下对细胞杀伤作用较轻,随着药物浓度的增加,细胞生长抑制,其作用特点表现为明显的浓度依赖性,九节龙皂苷Ⅰ对Mc3细胞作用的IC50值为9.98μg/ml。10μg/ml和20μg/ml的九节龙皂苷Ⅰ组的凋亡率分别为24.83%±0.08%和42.63%±0.07%,与对照组7.63%±0.14%相比,凋亡率明显增高。结论:九节龙皂苷Ⅰ可抑制口腔黏液表皮样癌Mc3细胞的增殖并诱导细胞凋亡。 Objective: To investigate the effect of ardipusilloside Ⅰ on the proliferation and apoptosis of mucoepidermoid carcinoma Mc3 cells.Methods: The inhibitory effect of ardipusilloside Ⅰ on Mc3 cells was measured by MTT assay.The apoptotic ratio and cell cycle analysis were determined by flow cytometry.Results:Ardipusilloside Ⅰ inhibited the proliferation of Mc3 cells in a dose-dependent manner.The IC50 value of ardipusilloside Ⅰ against Mc3 cells was 9.98 μg/ml.The apoptosis rates in 10 μg/ml and 20 μg/ml groups were 24.83%±0.08% and 42.63%±0.07% respectively,much higher than that in control group(7.63%±0.14%).Conclusion: Ardipusilloside Ⅰ can inhibit the proliferation and induce apoptosis of mucoepidermoid carcinoma Mc3 cells.
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2011年第2期208-211,共4页 Journal of Practical Stomatology
基金 国家科学自然基金(编号:30973623) 国家科技重大专项(编号:2009ZX09301-009)
关键词 口腔黏液表皮样癌 九节龙皂苷Ⅰ 细胞凋亡 Mc3细胞 Human mucoepidermoid carcinoma Ardipusilloside Ⅰ Apoptosis Mc3 cells
  • 相关文献

参考文献4

二级参考文献19

  • 1关晓峰,邱蔚六,何荣根,林国础,周晓健.肺高转移性涎腺腺样囊性癌细胞株的筛选[J].中华口腔医学杂志,1996,31(2):74-77. 被引量:39
  • 2孙定人 张石革 梁之江.中国临床新药集[M].北京:中国医药科技出版社,2001.715-716.
  • 3Wu JZ, Situ ZQ, Chen J,et al. Chemosensitivity of salivarygl and and oral cancer cell lines. Chin Med J, 1992,105(12) :1026.
  • 4Tsai CM, Hsiao SH, Frey CM, et al. Combination cytotoxic effects of cis-diamminedichloroplatinum ( Ⅱ ) and 5-fluorouracil with and without leucovorin against human nonsmall cell lung cancer cell lines. Cancer Res, 1993,53(5):1079.
  • 5Kantarjian HM, Talpaz M, Santini V, et al. Homoharringtonine : History, current research, and futurre direction. Cancer , 2001,92(6): 1591.
  • 6Kantarjian HM, Talpaz M, Smith TL, et al. Homoharringtonine and low-dose eytarabine in the management of late chronic-phase chronic myelogenous leukemia. J Clin Oncol,2000,18(20) : 3513.
  • 7缪振春,有机化学,1991年,11卷,517页
  • 8王晓娟,中国中药杂志,1990年,15卷,38页
  • 9赵萍萍,药学学报,1987年,22卷,70页
  • 10关雄泰,中草药,1987年,18卷,340页

共引文献69

同被引文献29

  • 1陶小军,龙静雯,贺建宇,姚鸿萍,刘静,曹永孝.九节龙皂苷Ⅰ的抗肿瘤作用和免疫调节作用[J].中国药理学通报,2005,21(9):1070-1073. 被引量:27
  • 2Bell RB Dierks E J Homer L.唾液腺恶性肿瘤患者的处理及结果[J].中国口腔颌面外科杂志,2005,3(3):271-271. 被引量:10
  • 3Sathomsumetee S,Rich J N,Reardon D A.Diagnosis and treat-ment of high-grade astrocytoma[J].Neurologic Clinics,2007,25(4):1111-1139.
  • 4Wesseling P,Kros J M,Jeuken J W M.The pathological diagno-sis of diffuse gliomas:towards a smart synthesis of microscopicand molecular information in a multidisciplinary context[J].Di-agn Histopathol,2011,17(11):486-494.
  • 5Man S L,Gao W Y,Zhang Y J,et al.Chemical study and med-ical application of saponins as anti-cancer agents[J].Fitotera-pia,2010,81(7):703-714.
  • 6Xiong J,Cheng G,Tang H F,et al.Ardipusilloside I inducesapoptosis in human glioblastoma cells through a caspase-8-inde-pendent FasL/Fas-signaling pathway[J].Environ Toxicol Phar-macol,2009,27(2):264-270.
  • 7Zhang Y M,Qu Y,Wang X J,et al.Ardipusilloside I purifiedfrom Ardisia pusilla competitively binds VEGFR and induces ap-optosis in NCI-H460 cells[J].Phytomedicine,2010,17(7):519-526.
  • 8Kim Y J,Stolarska M A,Othmer H G.The role of the microen-vironment in tumor growth and invasion[J].Prog Biophys MolBiol,2011,106(2):353-379.
  • 9Liotta L A,Steeg P S,Stetler-Stevenson W G.Cancer metastasisand angiogenesis:an imbalance of positive and negative regula-tion[J].Cell,1991,64(2):327-336.
  • 10Kupai K,Szucs G,Cseh S,et al.Matrix metalloproteinase ac-tivity assays:Importance of zymography[J].J Pharmacol ToxicolMethods,2010,61(2):205-209.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部